Acne is a skin disease that involves the oil glands at the base of hair follicles. The glands are stimulated by male hormones produced by the adrenal glands of both males and females. Hormonal changes lead to the skin becoming sensitive to a hormone known as DHT. The skin responds by increasing sebum production, decreasing natural skin cell shredding meaning dead skin cells clump together and form a plug in the pilo-sebaceous duct.
The skin bacteria start to digest the plug and produce by-products which cause inflammation. Bacteria is therefore not the cause of acne but it is their response to the changes in the skin which leads to spots. We have a range of products and treatment protocols designed to treat and control the symptoms and causes of acne.
TEBISKIN® Gly-Clean – is a delicate cleanser with a keratoplastic effect designed to cleanse the skin in preparation for treating acne where the skin is congested, with blackheads, whiteheads and where hyper keratinisation and hyper cornification maybe an issue. Sensitive or angry skins may use Tebiskin® Sooth-clean.
TEBISKIN® Sooth-Clean – is a delicate cleanser with anti-inflammatory properties specifically designed to cleanse skin post treatment. TEBISKIN® Sooth Clean is particularly appropriate for patients with angry or sore sensitive skin. Uses non detergent based cleansing agents.
TEBISKIN® OSK – for the control of acne and seborrhea, especially inflammatory acne. Inhibits inflammation, has a significant antibacterial effect and slows sebum production rates while also exhibiting a comedolytic effect to reduce skin thickening.
TEBISKIN® UV-OSK – for UV protection in acneic patients while delivering an anti-acne activity by inhibiting bacterial colonisation and resisting the hydrolysis of tryglicerides and the consequent release of pro-inflammatory free fatty acids. SPF 30 UVa and UVb.
The above TEBISKIN® products should be used in conjunction with our ENERPEEL® Salicylic Acid or ENERPEEL® Jessners to treat and control more resistant acne and acne scarring. All protocols have been properly researched and evaluated by leading dermatological research centres across Europe.